ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 6645

$1.59M Total Retail Price of All Prescriptions

Rank: 125 out of 6645

663 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 17,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 928 885 1 2
OMEPRAZOLE 795 738 2 6
LOSARTAN POTASSIUM 613 592 3 12
FLUTICASONE PROPIONATE 507 454 4 26
HYDROCHLOROTHIAZIDE 481 459 5 9
ALENDRONATE SODIUM 479 458 6 14
MELOXICAM 474 444 7 46
TRIAMCINOLONE ACETONIDE 447 424 8 55
SIMVASTATIN 445 401 9 1
GABAPENTIN 411 384 10 18
NEXIUM 382 363 11 40
METFORMIN HCL 381 361 12 7
METOPROLOL SUCCINATE 334 309 13 24
DIOVAN 324 306 14 19
PATANOL 322 304 15 131
LOVAZA 297 293 16 68
NASONEX 297 270 16 126
AMOXICILLIN 278 257 18 107
GLIMEPIRIDE 267 260 19 47
CRESTOR 266 265 20 34
PROAIR HFA 263 250 21 32
ATENOLOL 249 237 22 8
SINGULAIR 237 219 23 76
LIDODERM 228 215 24 53
JANUVIA 213 210 25 38
TRAMADOL HCL 209 201 26 30
LOPERAMIDE 205 188 10 27 281
TAMSULOSIN HCL 187 176 28 22
LOSARTAN-HYDROCHLOROTHIAZIDE 186 178 29 62
DIOVAN HCT 174 164 30 64
ALLOPURINOL 173 164 31 31
ATELVIA 172 166 32 91
PATADAY 169 148 33 183
QVAR 166 151 34 103
FAMOTIDINE 162 145 35 33
CREON 156 155 36 114
ZOLPIDEM TARTRATE 155 149 37 17
MONTELUKAST SODIUM 153 137 38 128
METOPROLOL TARTRATE 150 147 39 13
BENAZEPRIL HCL 150 139 39 21
ATORVASTATIN CALCIUM 138 128 41 10
GLYBURIDE-METFORMIN HCL 137 125 R 42 95
VENTOLIN HFA 133 115 43 146
AZITHROMYCIN 132 124 44 44
PANTOPRAZOLE SODIUM 132 126 44 29
ADVAIR DISKUS 125 108 46 45
FENOFIBRATE 119 112 47 74
VOLTAREN 116 115 48 108
ACARBOSE 110 109 49 211
PRAVASTATIN SODIUM 108 105 50 20
CIPROFLOXACIN HCL 105 96 51 67
MEGESTROL ACETATE 100 97 R 52 104
FUROSEMIDE 99 99 53 11
CELEBREX 98 89 54 54
CARVEDILOL 96 90 55 25
GLIPIZIDE 93 80 56 23
FINASTERIDE 88 85 57 73
IBUPROFEN 88 72 57 42
FLUOCINONIDE 85 75 59 130
ACTOS 85 81 59 71
LEVOTHYROXINE SODIUM 82 72 61 4
ULORIC 81 81 62 227
SPIRIVA 80 62 63 65
AMLODIPINE BESYLATE-BENAZEPRIL 79 79 64 97
COLCRYS 75 72 65 192
LIPITOR 75 70 65 69
CEPHALEXIN 73 64 67 111
CLOPIDOGREL 72 68 68 36
TRILIPIX 71 66 69 178
GLYBURIDE 70 65 R 70 58
AVODART 69 69 71 99
VESICARE 66 66 72 148
TRIAMTERENE-HCTZ 65 55 73 52
NABUMETONE 64 53 74 190
DONEPEZIL HCL 62 61 75 27
ZENPEP 60 58 76 210
HYDROCODONE-ACETAMINOPHEN 58 57 S3 77 5
PLAVIX 56 54 78 49
EXFORGE 55 53 79 155
TERAZOSIN HCL 53 52 80 48
IBANDRONATE SODIUM 53 46 80 147
ONGLYZA 51 48 82 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.